Region Skane Lasarettet I Landskrona

At Region Skane Lasarettet I Landskrona, the clinical research portfolio includes cardiovascular diseases with a focus on heart failure with preserved ejection fraction. The studies are designed to explore whether adding new treatment approaches to usual care can improve outcomes for patients living with this condition.

• Evaluating therapies aimed at reducing heart failure hospitalizations and cardiovascular death
• Studying treatment strategies for heart failure with preserved ejection fraction
• Comparing added mineralocorticoid receptor antagonist treatment with standard care

This work at the Hjärtkliniken reflects a practical, patient-centered effort to better understand how everyday treatment choices may improve long-term heart outcomes.

The site also supports research in neoplasms, specifically primary or recurrent non-muscle invasive bladder cancer with an intermediate risk of recurrence. These trials are focused on helping determine which postoperative bladder treatments are most effective at lowering the chance of cancer returning.

• Assessing whether adjuvant gemcitabine can improve recurrence-free survival
• Comparing two intravesical therapy options after transurethral tumour resection
• Supporting better treatment decisions for bladder cancer care

This research aims to strengthen evidence on how to prevent recurrence and improve outcomes for people treated for non-muscle invasive bladder cancer.